Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2015-06-02 Director's Dealing
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2015-06-02 English
Regulatory Filings 2015
Regulatory Filings
2015-06-02 English
PRELIMINARY NOTICE AND PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PRELIMINARY NOTICE AND PROXY STATEMENT' and is identified as a Schedule 14A filing with the SEC. It contains detailed information about a Special Meeting of Stockholders, including voting instructions, proposals (notably a reverse stock split), board recommendations, and proxy card information. The content is consistent with materials sent to shareholders to solicit votes for corporate actions. It is not an annual report, earnings release, or other financial report but a proxy solicitation document. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full proxy statement, not just a brief announcement.
2015-05-27 English
OWNERSHIP DOCUMENT
Director's Dealing
2015-03-24 English
SCHEDULE 13D
Major Shareholding Notification
2015-03-23 English
CURRENT REPORT ON FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content details entry into material definitive agreements, specifically securities purchase agreements and amendments related to a merger and share transactions. It includes descriptions of agreements, terms, and related corporate actions but does not contain financial statements or detailed financial performance data. The document is not an annual or quarterly report, earnings release, or management discussion. It is primarily an announcement of financing-related agreements and transactions. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2015-03-16 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.